Strs Ohio Takes Position in AVANOS MEDICAL, INC. $AVNS

Key Points

• Strs Ohio has acquired a new position in AVANOS MEDICAL, purchasing 32,100 shares valued at approximately $460,000 during the first quarter of the year.
• AVANOS MEDICAL reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18, with a negative net margin of 66.89% but a revenue of $175 million.
• Institutional investors own 95.17% of AVANOS MEDICAL's stock, reflecting significant interest from hedge funds and other entities.

Strs Ohio acquired a new position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 32,100 shares of the company's stock, valued at approximately $460,000. Strs Ohio owned approximately 0.07% of AVANOS MEDICAL as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of AVNS. Bank of America Corp DE boosted its position in shares of AVANOS MEDICAL by 2.5% in the fourth quarter. Bank of America Corp DE now owns 63,672 shares of the company's stock worth $1,014,000 after buying an additional 1,537 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of AVANOS MEDICAL by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company's stock worth $411,000 after buying an additional 901 shares during the period. ProShare Advisors LLC boosted its position in shares of AVANOS MEDICAL by 44.4% in the fourth quarter. ProShare Advisors LLC now owns 13,693 shares of the company's stock worth $218,000 after buying an additional 4,210 shares during the period. State of Wyoming boosted its position in shares of AVANOS MEDICAL by 132.0% in the fourth quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after buying an additional 2,923 shares during the period. Finally, Two Sigma Investments LP boosted its position in shares of AVANOS MEDICAL by 20.6% in the fourth quarter. Two Sigma Investments LP now owns 72,701 shares of the company's stock worth $1,157,000 after buying an additional 12,422 shares during the period. Institutional investors and hedge funds own 95.17% of the company's stock.

AVANOS MEDICAL Price Performance

AVNS opened at $12.15 on Tuesday. The stock has a market cap of $563.90 million, a price-to-earnings ratio of -1.21 and a beta of 1.12. AVANOS MEDICAL, INC. has a 1 year low of $9.30 and a 1 year high of $24.39. The company has a current ratio of 2.64, a quick ratio of 1.58 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average price of $11.62 and a 200 day moving average price of $12.43.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). AVANOS MEDICAL had a negative net margin of 66.89% and a positive return on equity of 6.16%. The company had revenue of $175.00 million for the quarter, compared to the consensus estimate of $165.50 million. During the same quarter last year, the business earned $0.34 earnings per share. AVANOS MEDICAL has set its FY 2025 guidance at 0.750-0.950 EPS. Analysts forecast that AVANOS MEDICAL, INC. will post 1.32 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently commented on AVNS. Zacks Research raised AVANOS MEDICAL to a "hold" rating in a research report on Tuesday, August 12th. Wall Street Zen cut AVANOS MEDICAL from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of "Hold".

Insiders Place Their Bets

In related news, Director Gary Blackford bought 40,000 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were bought at an average cost of $10.99 per share, for a total transaction of $439,600.00. Following the completion of the acquisition, the director directly owned 40,000 shares in the company, valued at approximately $439,600. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.64% of the stock is currently owned by company insiders.

About AVANOS MEDICAL

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.